SS Innovations International (NASDAQ:SSII) Shares Rise 10.2%

Analysts remain bearish on the stock despite the recent price increase.

Published on Feb. 15, 2026

Got story updates? Submit your updates here. ›

Shares of SS Innovations International, Inc. (NASDAQ:SSII) rose 10.2% on Friday, trading as high as $4.40 before closing at $4.33. Approximately 49,850 shares were traded, down 59% from the average daily volume of 121,455 shares. One analyst has a 'sell (e+)' rating on the stock.

Why it matters

The stock price increase comes despite the company's negative return on equity of 34.13% and negative net margin of 32.10%. Institutional investors have also been purchasing shares, with several firms like PNC Financial Services Group Inc. and Goldman Sachs Group Inc. taking new positions in the last year.

The details

SS Innovations International, Inc. is a medical device company that develops and manufactures surgical robotics. The company has a research agreement with the University of Central Florida to develop navigation and control technologies for medical robotics.

  • The stock price increase occurred on Friday, February 15, 2026.
  • SS Innovations International last reported earnings on Tuesday, January 13, 2026.

The players

SS Innovations International, Inc.

A medical device company that develops and manufactures surgical robotics.

Weiss Ratings

An investment research firm that has rated SS Innovations International stock as a 'sell (e+)'.

PNC Financial Services Group Inc.

An institutional investor that purchased a new position in SS Innovations International in the last year.

Goldman Sachs Group Inc.

An institutional investor that purchased a new position in SS Innovations International in the last year.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident (San Francisco Chronicle)

The takeaway

Despite the recent stock price increase, analysts remain bearish on SS Innovations International due to the company's negative financial metrics. The stock's performance will likely continue to be closely watched by investors as the company navigates the competitive medical robotics market.